Compumedics Limited (ASX:CMP)

Compumedics Statistics

Total Valuation

Compumedics has a market cap or net worth of AUD 66.42 million. The enterprise value is 77.61 million.

Market Cap	66.42M
Enterprise Value	77.61M

Important Dates

The last earnings date was Sunday, February 22, 2026.

Earnings Date	Feb 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Compumedics has 199.76 million shares outstanding. The number of shares has increased by 75.35% in one year.

Current Share Class	199.76M
Shares Outstanding	199.76M
Shares Change (YoY)	+75.35%
Shares Change (QoQ)	+2.79%
Owned by Insiders (%)	53.77%
Owned by Institutions (%)	2.95%
Float	71.99M

Valuation Ratios

The trailing PE ratio is 587.79 and the forward PE ratio is 22.17.

PE Ratio	587.79
Forward PE	22.17
PS Ratio	1.14
PB Ratio	2.84
P/TBV Ratio	12.91
P/FCF Ratio	15.35
P/OCF Ratio	15.20
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.19, with an EV/FCF ratio of 17.93.

EV / Earnings	686.81
EV / Sales	1.33
EV / EBITDA	17.19
EV / EBIT	25.35
EV / FCF	17.93

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.57.

Current Ratio	1.15
Quick Ratio	0.61
Debt / Equity	0.57
Debt / EBITDA	2.97
Debt / FCF	3.10
Interest Coverage	2.09

Financial Efficiency

Return on equity (ROE) is 0.50% and return on invested capital (ROIC) is 0.59%.

Return on Equity (ROE)	0.50%
Return on Assets (ROA)	3.75%
Return on Invested Capital (ROIC)	0.59%
Return on Capital Employed (ROCE)	12.05%
Weighted Average Cost of Capital (WACC)	4.95%
Revenue Per Employee	334,229
Profits Per Employee	646
Employee Count	175
Asset Turnover	1.15
Inventory Turnover	1.93

Taxes

In the past 12 months, Compumedics has paid 1.58 million in taxes.

Income Tax	1.58M
Effective Tax Rate	93.31%

Stock Price Statistics

The stock price has increased by +16.49% in the last 52 weeks. The beta is 0.28, so Compumedics's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+16.49%
50-Day Moving Average	0.36
200-Day Moving Average	0.32
Relative Strength Index (RSI)	41.63
Average Volume (20 Days)	95,861

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Compumedics had revenue of AUD 58.49 million and earned 113,000 in profits. Earnings per share was 0.00.

Revenue	58.49M
Gross Profit	31.24M
Operating Income	3.06M
Pretax Income	1.69M
Net Income	113,000
EBITDA	3.57M
EBIT	3.06M
Earnings Per Share (EPS)	0.00

Balance Sheet

The company has 2.00 million in cash and 13.40 million in debt, with a net cash position of -11.39 million or -0.06 per share.

Cash & Cash Equivalents	2.00M
Total Debt	13.40M
Net Cash	-11.39M
Net Cash Per Share	-0.06
Equity (Book Value)	23.37M
Book Value Per Share	8.75
Working Capital	4.28M

Cash Flow

In the last 12 months, operating cash flow was 4.37 million and capital expenditures -43,000, giving a free cash flow of 4.33 million.

Operating Cash Flow	4.37M
Capital Expenditures	-43,000
Free Cash Flow	4.33M
FCF Per Share	0.02

Margins

Gross margin is 53.42%, with operating and profit margins of 5.24% and 0.19%.

Gross Margin	53.42%
Operating Margin	5.24%
Pretax Margin	2.89%
Profit Margin	0.19%
EBITDA Margin	6.10%
EBIT Margin	5.24%
FCF Margin	7.40%

Dividends & Yields

Compumedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-75.35%
Shareholder Yield	-75.35%
Earnings Yield	0.17%
FCF Yield	6.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6